I’m not even worried about SAVA’s impact on Anavex. If anything, SAVA should be concerned about Blarcamesine making their drug obsolete or redundant. From everything I’ve read, Blarcamesine’s MOA (Mode of Action) occurs earlier in the cascade of events that lead up to full blown Alzheimer’s.